Nintedanib (BIBF 1120) in Mesothelioma
Clinical trial NCT01907100 · TERMINATED
Trial details
- NCT number
- NCT01907100
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-19
- Primary completion
- 2018-03-16
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.